Theodore T. PierceArinc OzturkSarah P. SherlockGuilherme Moura CunhaX J WangQian LiDavid HuntMichael S. MiddletonMarian MartinKathleen E. CoreyHannah EdenbaumSudha S. ShankarH.O. HeymannTania N. KamphausRoberto A. CalleYesenia CovarrubiasRohit LoombaNancy A. ObuchowskiArun J. SanyalClaude B. SirlinKathryn J. FowlerAnthony E. Samir
This prospective study defines expected US elastography measurement variability to guide clinical interpretation, enable diagnostic enrichment in clinical trials, and support U.S. Food and Drug Administration biomarker validation for nonalcoholic fatty liver disease.
Suzanne R. SharptonNobuharu TamakiRicki BettencourtEgbert MadambaJinho JungAmy LiuCynthia BehlingMark A. ValasekRohit Loomba
Adele TaibbiSalvatore PettaDomenica MatrangaGiovanni CaruanaRoberto CannellaGabriele BusèV. Di MarcoMassimo MidiriTommaso Vincenzo Bartolotta
Dimitrios S. KaragiannakisGeorgios MarkakisDimitra LakiotakiΕvangelos CholongitasJiannis VlachogiannakosGeorge Papatheodoridis